Skip to main content

Advertisement

Table 4 Association of independent factors with metabolic syndrome among HIV infected patients using ART at Hawassa, southern Ethiopia

From: Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia

Explanatory variable Metabolic syndrome by using IDF criteria Metabolic syndrome by using NCEP-ATP criteria
Presence of MetS = N (%) COR (95 % CI) AOR (95 % CI) Presence of MetS = N (%) COR (95 % CI) AOR (95 % CI)
BMI (kg/m2)
 ≤25 30 (16.2) 1.00 1.00 21 (11.3) 1.00 1.00
 >25 15 (8.1) 3.0 (1.3–6.5) 3.8 (1.5–9.8) 12 (6.5) 3.2 (1.4–7.4) 3.4 (1.3–9.2)
 p value   0.006 0.005   0.006 0.01
Gender
 Male 6 (3.2) 1.00 1.00 12 (6.5) 1.00 1.00
 Female 39 (21.1) 5.1 (2.0–12.9) 7.9 (2.6–24.1) 21 (11.3) 1.0 (0.47–2.3) 1.5 (0.24–1.8)
 p value   <0.0001 <0.0001   0.19 0.43
Age (years)
 ≤40 41 (22.1) 1.00 1.00 25 (13.5) 1.00 1.00
 >40 4 (2.1) 0.66 (0.21–2.0) 2.0 (0.45–9.5) 8 (4.3) 3.1 (1.2–8.3) 3.8 (1.0–13.7)
 p value   0.21 0.35   0.02 0.04
ART use (months)
 ≤48 22 (11.9) 1.00 1.00 20 (10.8) 1.00 1.00
 >48 23 (12.4) 1.8 (0.95–3.7) 2.3 (1.0–5.4) 13 (7.0) 0.99 (0.46–2.1) 0.8 (0.32–1.9)
 p value   0.07 0.04   0.20 0.33
Cigarette
 Never smoke 43 (23.2) 1.00 1.00 28 (15.1) 1.00 1.00
 Still smoking 2 (1.1) 0.26 (0.06–1.1) 0.17 (0.03–1.0) 5 (2.7) 1.3 (0.45–3.9) 0.47 (0.10–2.1)
 p value   0.08 0.05   0.18 0.33
Education
 Illiterate 1 (0.5) 1.00 1.00 3 (1.6) 1.00 1.00
Primary 22 (11.9) 6.7 (0.8–53.3) 10.1 (1.1–94) 15 (8.1) 1.2 (0.31–4.7) 0.85 (0.17–4.3)
 p value   0.07 0.04   0.16 0.24
Secondary and above 22 (11.9) 6.2 (0.79–49.9) 10.9 (1.1–104) 15 (8.1) 1.1 (0.3–4.4) 1.1 (0.45–2.8)
 p value   0.08 0.04   0.21 0.37
  1. ART antiretroviral therapy, COR crude odds ratio, AOR adjusted odds ratio, CI confidence interval, BMI body mass index, EFV Efavirenz, NVP Nevirapine, NNRTI non nucleoside reverse transcriptase inhibitors